Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-05 Sale(A) | 2024-02-16 4:34 pm | Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER | 1,208 | $2.91 | $3,515 | 83,804 (Direct) | View |
| 2023-01-05 Sale | 2024-01-08 4:42 pm | Athira Pharma Inc. | ATHA | Gengos Andrew See Below | 1,208 | $2.91 | $3,515 | 83,804 (Direct) | View |
| 2023-06-07 Purchase | 2023-06-09 5:06 pm | Athira Pharma Inc. | ATHA | Gengos Andrew See Below | 15,000 | $3.4297 | $51,445 | 80,012 (Direct) | View |
| 2023-06-02 Purchase | 2023-06-06 7:36 pm | Athira Pharma Inc. | ATHA | Gengos Andrew See Below | 65,012 | $2.9467 | $191,572 | 65,012 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-14 Option Award | 2024-02-16 4:48 pm | N/A 2034-02-13 | Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER | 280,000 | $0 | 280,000 (Direct) | View |
| 2024-01-04 Option Award(A) | 2024-02-16 4:34 pm | N/A N/A | Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER | 5,000 | $0 | 83,804 (Direct) | View |
| 2023-01-04 Option Award | 2024-01-08 4:42 pm | N/A N/A | Athira Pharma Inc. | ATHA | Gengos Andrew See Below | 5,000 | $0 | 83,804 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-22 5:53 pm | N/A 2033-05-17 | Athira Pharma Inc. | ATHA | Gengos Andrew See Below | 400,000 | $0 | 400,000 (Direct) | View |
Ownership | 2023-05-22 5:51 pm | N/A N/A | Athira Pharma Inc. | ATHA | Gengos Andrew See Below | 0 | $0 | 0 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 4:57 pm | N/A 2032-02-22 | Cyteir Therapeutics Inc. | CYT | Gengos Andrew Chief Business Officer | 35,000 | $0 | 35,000 (Direct) | View |
Ownership | 2021-06-17 9:15 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Gengos Andrew Chief Business Officer | 0 | $0 | 378,682 (Direct) | View |